Department of Psychology and Behavioural Sciences, Aarhus University, Aarhus, Denmark.
Danish Committee for Health Education, Copenhagen, Denmark.
Pain. 2017 Aug;158(8):1437-1445. doi: 10.1097/j.pain.0000000000000931.
The Stanford Chronic Pain Self-Management Programme (CPSMP) consists of 6 2½-hour weekly workshops focusing on how to manage pain in daily life. The workshops are facilitated by 2 workshop leaders of whom at least 1 must suffer from a long-term pain condition. The program is highly structured and manualized. Only few controlled trials testing the effect of CPSMP exist. Enrolled in the study were 424 adults from 19 Danish municipalities, (72% women; age: 25-93 years) with pain of any etiology and great variation in pain history (0-50 yrs). Of these, 216 were randomized to a lay-led version of the CPSMP. The primary outcome was pain-related disability. Secondary outcomes were pain, pain catastrophizing, self-efficacy, emotional distress, physical symptoms, and illness worry. Outcomes were measured before randomization, immediately after the CPSMP (response rate: 94%), and at 3-month follow-up (response rate: 92%). National register data on health expenditure were obtained to examine effects on health care use. ClinicalTrials.gov Identifier: NCT01306747. The CPSMP had no effect on the primary outcome pain-related disability or on health expenditure during intervention and follow-up period. Small positive effects on emotional distress and illness worry 3 months after CPSMP were observed. Lay-led CPSMP is not recommended as treatment for chronic pain-related disability. This heterogeneous group of patients with pain did not benefit from the CPSMP except for a small, but clinically insignificant improvement in psychological well-being.
斯坦福慢性疼痛自我管理计划（CPSMP）由 6 个为期 2 个半小时的每周研讨会组成，重点是如何在日常生活中管理疼痛。研讨会由 2 名研讨会领导者主持，其中至少有 1 名必须患有长期疼痛疾病。该计划高度结构化和规范化。仅有少数对照试验测试了 CPSMP 的效果。该研究招募了来自丹麦 19 个市的 424 名成年人，（72%为女性；年龄：25-93 岁）患有任何病因的疼痛，且疼痛史差异很大（0-50 年）。其中，216 人随机分配到由非专业人员领导的 CPSMP 版本。主要结局是与疼痛相关的残疾。次要结局是疼痛、疼痛灾难化、自我效能、情绪困扰、身体症状和疾病担忧。在随机分组前、CPSMP 后立即（应答率：94%）和 3 个月随访时（应答率：92%）测量结局。为了检查对医疗保健使用的影响，获得了国家登记数据中关于健康支出的数据。临床试验.gov 标识符：NCT01306747。CPSMP 对主要结局与疼痛相关的残疾或干预和随访期间的医疗支出没有影响。CPSMP 3 个月后观察到情绪困扰和疾病担忧的小的积极影响。不建议将非专业人员领导的 CPSMP 作为慢性疼痛相关残疾的治疗方法。除了心理健康有小的、但临床上无意义的改善外，这群患有疼痛的异质患者并未从 CPSMP 中受益。
